Page last updated: 2024-08-23

daunorubicin and Granulocytic Leukemia, Chronic, Stable Phase

daunorubicin has been researched along with Granulocytic Leukemia, Chronic, Stable Phase in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	6 (85.71)	18.2507
2000's	1 (14.29)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Calvert, L; Claxton, D; Durett, A; Giralt, S; Hamer, J; Kantarjian, H; Khouri, I; Liang, J; Talpaz, M; Tibbits, P	1
Helminen, P; Koskimies, S; Lukka, M; Pakkala, S; Ruutu, T	1
Baccarani, M; Damiani, D; Fanin, R; Michelutti, A; Michieli, M; Russo, D	1
Kuyama, J; Take, H	1
Beran, M; Cortes, J; Giles, FJ; Kantarjian, H; Keating, M; Koller, C; O'Brien, S; Rios, MB; Talpaz, M	1
Chan, TK; Chiu, E; Liang, R; Todd, D	1
Ahmed, T; Arlin, Z; Biguzzi, S; Feldman, E; Mittelman, A; Puccio, C	1

Trials

1 trial(s) available for daunorubicin and Granulocytic Leukemia, Chronic, Stable Phase

Article	Year
Results of therapy with interferon alpha and cyclic combination chemotherapy in patients with philadelphia chromosome positive chronic myelogenous leukemia in early chronic phase. Leukemia & lymphoma, 2001, Volume: 41, Issue:3-4 Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cyclophosphamide; Cytarabine; Cytogenetic Analysis; Daunorubicin; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Male; Middle Aged; Prednisolone; Prednisone; Risk Factors; Survival Rate; Therapeutic Equivalency; Treatment Outcome; Vincristine	2001

Article

Year

Results of therapy with interferon alpha and cyclic combination chemotherapy in patients with philadelphia chromosome positive chronic myelogenous leukemia in early chronic phase.

Leukemia & lymphoma, 2001, Volume: 41, Issue:3-4

Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cyclophosphamide; Cytarabine; Cytogenetic Analysis; Daunorubicin; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Male; Middle Aged; Prednisolone; Prednisone; Risk Factors; Survival Rate; Therapeutic Equivalency; Treatment Outcome; Vincristine

2001

Other Studies

6 other study(ies) available for daunorubicin and Granulocytic Leukemia, Chronic, Stable Phase

Article	Year
Percentage of Philadelphia chromosome (Ph)-negative and Ph-positive cells found after autologous transplantation for chronic myelogenous leukemia depends on percentage of diploid cells induced by conventional-dose chemotherapy before collection of autolog Blood, 1995, Jun-01, Volume: 85, Issue:11 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Bone Marrow Transplantation; Cell Survival; Colony-Forming Units Assay; Combined Modality Therapy; Cyclophosphamide; Daunorubicin; Diploidy; Etoposide; Female; Genetic Markers; Hematopoietic Stem Cells; Humans; Idarubicin; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Accelerated Phase; Leukemia, Myeloid, Chronic-Phase; Male; Middle Aged; Mitoxantrone; Neoplastic Stem Cells; Philadelphia Chromosome; Remission Induction; Survival Rate; Vidarabine; Whole-Body Irradiation	1995
Paternity after bone marrow transplantation following conditioning with total body irradiation. Bone marrow transplantation, 1994, Volume: 13, Issue:4 Topics: Adult; Bone Marrow Transplantation; Cyclophosphamide; Daunorubicin; DNA; DNA Fingerprinting; Female; Humans; Hypogonadism; Infant, Newborn; Leukemia, Myeloid, Chronic-Phase; Male; Oligospermia; Paternity; Pregnancy; Radiation Injuries; Remission Induction; Spermatogenesis; Whole-Body Irradiation	1994
P170 glycoprotein expression and impaired anthracycline retention in chronic myeloid leukaemia. Leukemia & lymphoma, 1995, Volume: 17, Issue:3-4 Topics: Antibodies, Monoclonal; ATP Binding Cassette Transporter, Subfamily B, Member 1; Daunorubicin; Drug Resistance, Multiple; Flow Cytometry; Humans; Idarubicin; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Accelerated Phase; Leukemia, Myeloid, Chronic-Phase	1995
[Reversion to chronic phase of chronic myelogenous leukemia in blast crisis with small-dose daunorubicin and oral prednisolone]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1995, Volume: 36, Issue:12 Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Daunorubicin; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Male; Prednisolone	1995
Non-aggressive therapy for chronic myeloid leukaemia in blastic transformation. Cancer chemotherapy and pharmacology, 1992, Volume: 29, Issue:4 Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Child; Cytarabine; Daunorubicin; Doxorubicin; Female; Humans; Hydroxyurea; Leukemia; Leukemia, Myeloid, Chronic-Phase; Male; Methotrexate; Middle Aged; Remission Induction; Thioguanine; Vincristine	1992
Intensive chemotherapy with interferon for induction of true remission in chronic phase of chronic myelogenous leukemia. Cancer investigation, 1990, Volume: 8, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Humans; Interferon Type I; Leukemia, Myeloid, Chronic-Phase; Male; Remission Induction	1990